ALLMedicine™ Acute Rhinosinusitis Center

Nov 11th, 2022 - Primary immunodeficiency disorders (PIDDs) may be a risk factor for development of recurrent acute rhinosinusitis (RARS). There are currently no clear guidelines for the timing and methodology of PIDD testing in patients with RARS. The aim of this...

Oct 19th, 2022 - Antibiotics are prescribed in >80% of outpatient acute rhinosinusitis (ARS) visits, despite the low incidence of bacterial infection. Previous studies have shown patient expectations are the most robust predictor of antibiotics prescription in ARS...

Oct 14th, 2022 - 'Man flu' is a popular term to describe hypersensitivity to acute rhinosinusitis (ARS) in men. While this pop-cultural description may influence the social perspective of ARS, so far, no prospective observational data on the gender-specific natura...

Oct 8th, 2022 - Antibacterial therapy in acute rhinosinusitis (ARS) is prescribed 4-9 times more often than recommended, while no >5 % of patients require such treatment. The main motive for the irrational antibiotic prescription is the presence of mucopurulent d...

Jul 12th, 2022 - Antibiotics are overused in patients with acute rhinosinusitis (ARS) as it is difficult to identify those who benefit from antibiotic treatment. To develop prediction models for computed tomography (CT)-confirmed ARS and culture-confirmed acute ba...

Sep 22nd, 2015 - Classifying Rhinosinusitis In April 2015, the American Academy of Otolaryngology-Head and Neck Surgery Foundation (AAO-HNSF) published an update[1] to a 2007 clinical practice guideline for the management of adult rhinosinusitis, a condition affec...